Cancer growth in bone requires the activation of various signaling pathways in cancer cells and stromal cells, including those stimulated by TGF-β and RANKL and mediated through Src tyrosine kinase, mTOR signaling mediated by mutations in TSC2 and the Wnt/β-catenin pathway [79,163]. The gene discussed is TNFSF11; the disease is cancer.